Common Contracts
1 similar Rating Agreement contracts
Date: July 26, 2021 Ref: ICRA/ Supriya Lifescience Ltd./26072021/1Rating Agreement • July 26th, 2021
Please refer to the Rating Agreement dated October 3, 2019 executed between ICRA Limited (“ICRA”) and your Company, whereby, ICRA is required to review its ratings, on an annual basis, or as and when the circumstances so warrant. Based on a review of the latest developments, the Rating Committee of ICRA, after due consideration has upgraded the long-term rating to [ICRA]A- (pronounced ICRA A minus) from [ICRA]BBB+ (pronounced ICRA triple B plus) (“Rating”). The Rating Committee of ICRA has also upgraded the short-term rating to [ICRA]A2+ (pronounced ICRA A two plus) from [ICRA]A2 (pronounced ICRA A two) (“Rating”). The outlook on the long-term rating is Stable. Instruments with this rating are considered to have adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk.
